Source: HCP general
More...
FDA’s Reclassifies Sharps Needle Destruction Device
Agency believes final order will decrease regulatory burden on manufacturers as they will no longer be required to submit a premarket approval application (PMA), but can instead submit a less-burdensome premarket notification (510(k)) before marketing this type of device